Table 1.

Characteristics of AML patients used in the study

Patient number	FAB subtype	Cytogenetic	Mutations
1	Non-M3	48,XY,add(4)(p16),+8, der(16)del(16)(p13.1p13.3), del(16)(q22q24)	NC
2	M4E	46,XX,inv(16)(p13.1q22)	NC
3	M1	Normal karyotype 46,XY	FLT3-ITD positive
4	M4E	46,XX,inv(16)(p13.3q22)	NC
5	M4E	46,XY,inv(16)	NPM-1 negative
			FLT-3 ITD negative
6	M5	Normal karyotype 46,XX	NPM-1 positive
			FLT-3 ITD positive
7	M1	46,XX, t(4;11) fusion transcripts (e10/e4 and e9/e5)	FLT3 ITD negative